Vote Scores
Filings read through

ProShares Ultra Nasdaq Biotechnology proxy votes

Voting season: year to 30 June 2026. The filing read date describes collection, not the voting period. Read the management-mark denominator.

Tickers
BIB
SEC series number
S000018718
Filer
PROSHARES TRUST
Fund family
ProShares and ProFunds
Season
year to 30 June 2026

ProShares Ultra Nasdaq Biotechnology is a series of PROSHARES TRUST. The filing reports 1,922 vote records for the series in the year to 30 June 2026. 426 of the 1,908 votes that the filing marks for or against management are against management (22.3%). The series reported 159 votes for and 35 votes against or abstaining on say-on-pay items in the year to 30 June 2026.

By vote records in the year to 30 June 2026, ProShares Ultra Nasdaq Biotechnology was number 2,069 of 5,303 fund series with 500 or more vote records. Its vote records fell by 0.2% from the year to 30 June 2025 to the year to 30 June 2026. The vote records of all fund series with a page in both years rose by 4.0%. In the year to 30 June 2026, category CORPORATE GOVERNANCE is 5.9% of its vote records. Across all fund series, it is 14.1%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: votes counted and the against-management share for the year to 30 June 2026. All recorded changes

What this site holds for one fund

Each vote record on Form N-PX names the series that cast it. From these records the site keeps counts for each series and season.

The counts are votes, votes with and against management, say-on-pay votes, votes on proposals from security holders, and votes by category.

The site does not keep the vote of ProShares Ultra Nasdaq Biotechnology at each company meeting. A company page shows the position of each fund family. A position is not the vote of each fund.

To see each vote of the series, open the filing of PROSHARES TRUST on EDGAR.

The record, year to 30 June 2026

Vote records
1,922
With management
1,482
Against management: 22.3% of the votes marked
426
Say-on-pay support, 159 of 194 votes
82.0%
Support for proposals from security holders, 2 of 6 votes
33.3%
ProShares Ultra Nasdaq Biotechnology beside its filer, its family and the median fund registrant, year to 30 June 2026
FigureThis seriesIts filerIts familyMedian fund registrant
Against-management share22.3%10.3%9.9%6.2%
Say-on-pay support82.0%88.1%88.5%91.6%
Support for proposals from security holders33.3%40.0%40.9%27.5%

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

Votes of ProShares Ultra Nasdaq Biotechnology by category, year to 30 June 2026Category names as Form N-PX prints them. A vote can carry more than one category.
CategoryVotesForAgainstAgainst management
DIRECTOR ELECTIONS1,0587605127.9%
SECTION 14A SAY-ON-PAY VOTES2311643516.0%
AUDIT-RELATED27027000.0%
SHAREHOLDER RIGHTS AND DEFENSES3300.0%
EXTRAORDINARY TRANSACTIONS181800.0%
CAPITAL STRUCTURE81631822.2%
COMPENSATION150866442.3%
CORPORATE GOVERNANCE1141001412.6%
ENVIRONMENT OR CLIMATE2110.0%
HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE1100.0%
DIVERSITY, EQUITY, AND INCLUSION2110.0%
OTHER SOCIAL ISSUES4220.0%

By season

ProShares Ultra Nasdaq Biotechnology, each season on file
SeasonVote recordsAgainst managementSay-on-pay supportSupport for proposals from security holders
year to 30 June 20261,92222.3%82.0%33.3%
year to 30 June 20251,92521.0%82.4%42.9%
year to 30 June 20241,64419.9%86.7%71.4%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. ProShares Ultra Nasdaq Biotechnology proxy votes, year to 30 June 2026. https://votescores.com/fund/s000018718-proshares-ultra-nasdaq-biotechnology/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

What share of the votes of ProShares Ultra Nasdaq Biotechnology is against management?
22.3% in the year to 30 June 2026: 426 of the 1,908 votes that the filing marks for or against management.
What does ProShares Ultra Nasdaq Biotechnology report on say-on-pay votes?
The series reported 159 votes for and 35 votes against or abstaining on say-on-pay items in the year to 30 June 2026.
Does this page show the vote of ProShares Ultra Nasdaq Biotechnology at one company?
Not on this site. The site keeps counts for each series. It does not keep the vote of a series at each meeting. The Form N-PX of PROSHARES TRUST on EDGAR lists each vote with the series that cast it.
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other holders voted or the result of a meeting.

Provenance: SEC EDGAR, the Form N-PX of PROSHARES TRUST (SEC filer number 1174610). The filer names the series that cast each vote. The filer wrote the filing. Ticker symbols come from the SEC mutual fund tickers file, matched on the series number. Filings read through .